Sulfacytine
Renoquid (sulfacytine) is a small molecule pharmaceutical. Sulfacytine was first approved as Renoquid on 1982-01-01. It is used to treat gram-negative bacterial infections, gram-positive bacterial infections, and urinary tract infections in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
infections | D007239 |
urogenital diseases | D000091642 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sulfacytine
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
RENOQUID | Glenwood | N-017569 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
gram-negative bacterial infections | — | D016905 | — |
gram-positive bacterial infections | — | D016908 | — |
urinary tract infections | EFO_0003103 | D014552 | N39.0 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
3 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Meibomian gland dysfunction | D000080343 | H02.88 | — | — | — | 1 | — | 1 |
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | SULFACYTINE |
INN | sulfacitine |
Description | Sulfacytine is a member of benzenes and a sulfonamide. |
Classification | Small molecule |
Drug class | antimicrobials (sulfonamides derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCn1ccc(NS(=O)(=O)c2ccc(N)cc2)nc1=O |
Identifiers
PDB | — |
CAS-ID | 17784-12-2 |
RxCUI | 78902 |
ChEMBL ID | CHEMBL1201056 |
ChEBI ID | — |
PubChem CID | 5322 |
DrugBank | DB01298 |
UNII ID | T795873AJP (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 14 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
648 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more